Granulocyte Colony-Stimulating Factor Use in a Large Iranian Hospital: Comparison with American Society of Clinical Oncology (ASCO) Clinical Practice Guideline

Background: Granulocyte Colony Stimulating Factors (GCSF) is high-cost agents commonly recommended for primary and secondary prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia. GCSFs have been shown to be beneficial in some patient subgroups, although they are probably overused...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousavi, Sarah, Dadpoor, Mina, Ashrafi, Farzaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888153/
https://www.ncbi.nlm.nih.gov/pubmed/27252808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888153/
https://www.ncbi.nlm.nih.gov/pubmed/27252808

Ejemplares similares